DOCS Doximity Inc: Enterprise Value to EBITDA Ratio

Graphic logo of Doximity (DOCS)

The digitalization of medicine through the elimination of paperwork minimizes environmental impact, as confirmed by the Doximity, Inc. (DOCS) EV/EBITDA multiple chart, where the metric holds at 25.35. Dominance among American physicians creates a powerful defensive barrier despite strict HIPAA regulations. However, growth is constrained by user base limits and potential reductions in advertising spend within the pharmaceutical sector.

Doximity Corp - DOCS Total Company Value to Operating Income Before Depreciation Ratio (period 11/23/2025 - 11/10/2026)

Analytical breakdowns for Doximity, Inc.

- market price and analyst price targets:
Price Chart Doximity Corp|DOCS - Average Forecast Price
- company stock capitalization data:
Market Valuation Doximity Network|DOCS - Business Value
- business book valuation details:
Book Value per Share Doximity|DOCS - Book Valuation of Business|Market Value to Book Value Ratio doximity.com|DOCS - Cumulative Company Assets
- company total debt and liquidity indicators:
Total Debt to Capital Doximity, Inc.|DOCS - Ratio of Long-Term Indebtedness to Capital|Short-Term Debt to Equity Ratio Doximity|DOCS - Company Cumulative Indebtedness|Debt to Book Value Doximity Network|DOCS - Long-Term Debt|Company Current Liabilities Doximity|Quick Ratio doximity.com
- financial results and valuation multiples details:
DOCS - Net Financial Result|Expected Profit Doximity, Inc.|DOCS - Price to Earnings Multiple|Forward P/E Multiple Doximity, Inc.|DOCS - Price/Earnings to Growth Multiple|Enterprise Value to EBITDA Ratio Doximity Network|DOCS - Operating income before deduction of amortization|Net earnings per share (EPS TTM) Doximity|DOCS - Earnings per share for the last 12 months|Year-over-year earnings per share growth for the last twelve months doximity.com|DOCS - Earnings per share growth rate in current year|Earnings growth forecast for next year Doximity, Inc.
General company analysis:Doximity Corp (DOCS)
Product sample of Doximity Inc

The long-term sustainability of the issuer is determined by its ability to generate operating profit that covers the total cost of the business, including debt. This ratio compares market capitalization and liabilities to EBITDA, allowing GURU.Markets to track capital management efficiency. By analyzing the EV/EBITDA trajectory of the company, an investor assesses the premium paid for the asset relative to its actual yield. For Doximity, Inc. (DOCS), this indicator confirms the capitalization of its status as an industry standard within the closed digital environment of US physicians.

Competitor analysis

Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Veeva Systems Inc VEEV|HealthEquity Building (HQY) - Company Value to EBITDA|WAY: Enterprise Value to EBITDA Ratio|CRVL (corvel.com) - Enterprise Value to Operating Income Before Depreciation|PRVA: EV/EBITDA Multiple|HURN - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Certara Corp|Enterprise Value to EBITDA Ratio Omnicell Health (OMCL)|EV/EBITDA Multiple GDRX|Total Company Value to Operating Income Before Depreciation Ratio schrodinger.com|Phreesia - Enterprise Value to EBITDA Ratio|Enterprise Value to Operating Income Before Depreciation Ratio OMDA (Omada Health, Inc.)|EVH: Enterprise Value to EBITDA Ratio|Company Value to EBITDA HealthStream Learning|DH (Definitive Healthcare) - Enterprise Value to EBITDA Ratio|consensus.com - Business Value to Operating Income Before Depreciation|AGL (agilon health) - EV/EBITDA Multiple|Absci Corp (ABSI) - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization SoYoung (SY)|National Research Corp. - Enterprise Value to Operating Income Before Depreciation|EV/EBITDA Multiple SPOK (Spok Holdings, Inc.)|OPRX - Enterprise Value to EBITDA Ratio|TBRG: Enterprise Value to EBITDA Ratio|Total Company Value to Operating Income Before Depreciation Ratio Simulations Plus Inc SLP|SOPH: EV/EBITDA Multiple|Enterprise Value to Operating Income Before Depreciation HCAT|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization CareCloud Inc.|Company Value to EBITDA researchsolutions.com RSSS|EV/EBITDA Multiple DLHC|Enterprise Value to EBITDA Ratio onemednet.com ONMD|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Scienture Holdings Inc. SCNX|Total Company Value to Operating Income Before Depreciation Ratio Healthcare Triangle Corporation (HCTI)|iSpecimen Corp - EV/EBITDA Multiple|Total Company Value to Operating Income Before Depreciation Ratio Bullfrog AI Holdings BFRG|WORX (SCWorx) - Enterprise Value to EBITDA Ratio|MSPR: Enterprise Value to Operating Income Before Depreciation Ratio|Enterprise Value to EBITDA Ratio ICCT|MEDS: Business Value to Operating Income Before Depreciation|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Orgenesis Inc. (ORGS)|Enterprise Value to EBITDA Ratio r1rcm.com RCM|EV/EBITDA Multiple SHCR (Sharecare)|Streamline Health Solutions, Inc. (STRM) - Company Value to EBITDA|Syra Health Corporation - EV/EBITDA Multiple|AMEH (Apollo Medical Holdings) - Enterprise Value to Operating Income Before Depreciation|MODN: EV/EBITDA Multiple|Enterprise Value to Operating Income Before Depreciation NXGN